YUSEI (00096) appoints He Xiangli as an independent non-executive director.
YUSEI (00096) announces the appointment of Mr. He Xiangli as an independent non-executive director, the chairman of the Company's Audit Committee, and a member of the Company's Remuneration Committee and Nomination Committee, effective from February 1, 2026.
YUSEI (00096) announces the appointment of Mr. He Xiangli as an independent non-executive director, Chairman of the Company Audit Committee, and member of the Company Remuneration Committee and Nomination Committee, effective from February 1, 2026.
Related Articles
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)
From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?
New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)
From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?
New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
